Unick Corporation (KOSDAQ:011320)

Market Cap	74.87B
Revenue (ttm)	389.32B
Net Income (ttm)	8.06B
Shares Out	19.32M
EPS (ttm)	416.85
PE Ratio	9.30
Forward PE	n/a
Dividend	45.00 (1.16%)
Ex-Dividend Date	Dec 27, 2024

Volume	33,644
Average Volume	30,558
Open	3,815.00
Previous Close	3,890.00
Day's Range	3,750.00 - 3,890.00
52-Week Range	3,155.00 - 4,865.00
Beta	1.04
RSI	47.62
Earnings Date	Aug 14, 2025

About Revance Therapeutics

Unick Corporation develops, manufactures, and sells automotive parts in South Korea. It offers transmission parts, such as solenoid valves, thermal bypass valves, and speed sensors; and engine parts, including solenoid valves for oil pumps, engine mount solenoid valves, pneumatic solenoid valves, and water level sensors. The company provides parts for emission control systems comprising bypass valves for emission reduction and pneumatic solenoid valves; cut, vent, and tank isolation valves for fuel control systems; and control valves for hydrog...

• Industry: Motor Vehicle Parts and Accessories
• Founded: 1971
• Employees: 58
• Stock Exchange: KOSDAQ
• Ticker Symbol: 011320

Financial Performance

In 2024, Unick's revenue was 374.80 billion, an increase of 13.94% compared to the previous year's 328.95 billion. Earnings were 7.72 billion, an increase of 20.87%.